Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study)
Drug Discoveries & Therapeutics · 30.04.2026 · 20 (2) · 175-189
DOI: 10.5582/ddt.2026.01008 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 30.04.2026. Verfasst von Toshimasa Shimizu und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Scienc…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antibodies, Monoclonal, Humanized, Pyridines, Antirheumatic Agents. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.
- Department of Community Medicine, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Department of Rheumatology, Kita-Harima Medical Center, Hyogo, Japan.
- Department of Rheumatology, University of Yamanashi Hospital, Yamanashi, Japan.
- Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
Zitieren
APA
Shimizu, T., Kawashiri, S. Y., Koga, T., Kiya, R., Morita, M., Kawasaki, R., Kuroda, S., Tashiro, S., Sato, S., Yabe, M., Misaki, K., Hanai, S., Nakagomi, D., Ogasawara, M., Tamura, N., Watanabe, R., Kanazawa, H., Atsumi, T., Ueki, Y., …, & Kawakami, A. (2026). Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study). Drug Discoveries & Therapeutics, 20(2), 175-189. https://doi.org/10.5582/ddt.2026.01008
Vancouver
Shimizu T, Kawashiri SY, Koga T, Kiya R, Morita M, Kawasaki R, et al. Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study). Drug Discoveries & Therapeutics. 2026;20(2):175-189. doi:10.5582/ddt.2026.01008
BibTeX
@article{Shimizu2026,
author = {Shimizu, Toshimasa and Kawashiri, Shin-Ya and Koga, Tomohiro and Kiya, Rieko and Morita, Michiko and Kawasaki, Rina and Kuroda, Shohei and Tashiro, Shigeki and Sato, Shuntaro and Yabe, Moemi and Misaki, Kenta and Hanai, Shunichiro and Nakagomi, Daiki and Ogasawara, Michihiro and Tamura, Naoto and Watanabe, Rina and Kanazawa, Hiroshi and Atsumi, Tatsuya and Ueki, Yukitaka and Okano, Tadashi and Suzuki, Takahisa and Takaoka, Hirokazu and Hamada, Hiroaki and Hidaka, Toshihiko and Furuta, Shunsuke and Hosogaya, Naoki and Yamamoto, Hiroshi and Kawakami, Atsushi},
title = {Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study)},
journal = {Drug Discoveries & Therapeutics},
year = {2026},
volume = {20},
number = {2},
pages = {175--189},
doi = {10.5582/ddt.2026.01008}
}
EUVIMED